We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
+21.35%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$2.04B
AUM Growth
+$120M
Cap. Flow
-$149M
Cap. Flow %
-7.33%
Top 10 Hldgs %
47.27%
Holding
257
New
21
Increased
32
Reduced
47
Closed
104

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$16.4M
2
TRAX
First Tracks Biotherapeutics
TRAX
+$14M
3
SE icon
Sea Limited
SE
+$11.9M
4
NU icon
Nu Holdings
NU
+$10.1M
5
GOSS icon
Gossamer Bio
GOSS
+$9.54M

Top Sells

Rank Stock Value
1
ASTH icon
Astrana Health
ASTH
+$17.6M
2
LLY icon
Eli Lilly
LLY
+$15.3M
3
GXO icon
GXO Logistics
GXO
+$14.8M
4
FOLD
Amicus Therapeutics
FOLD
+$11.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.9%
2 Healthcare 24.5%
3 Financials 7.3%
4 Consumer Discretionary 7.28%
5 Technology 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRESY
126
Cresud
CRESY
$845M
$561K 0.03%
50,000
-190,000
-79% -$2.18M
HRMY icon
127
PUT
Harmony Biosciences
HRMY
$2.42B
$535K 0.03%
14,700
– –
JATT
128
JATT II Acquisition Corp
JATT
$95.9M
$480K 0.02%
+42,264
New +$449K
ORIQ
129
Origin Investment Corp I
ORIQ
$89.8M
$309K 0.02%
30,000
– –
OPTU
130
Optimum Communications Inc
OPTU
$368M
$295K 0.01%
203,108
– –
MSTR icon
131
Strategy Inc
MSTR
$52.7B
$165K 0.01%
+1,900
New +$276K
SAAQW
132
Space Asset Acquisition Corp Warrants
SAAQW
$4.94M
$112K 0.01%
124,999
– –
CTMX icon
133
CytomX Therapeutics
CTMX
$771M
$75K ﹤0.01%
20,000
-405,000
-95% -$1.55M
GCTS.WS
134
GCT Semiconductor Holding Warrants
GCTS.WS
$14.5M
$62.3K ﹤0.01%
127,202
-438,979
-78% -$148K
ARCIW
135
Archimedes Tech SPAC Partners III Warrant
ARCIW
$37.5K ﹤0.01%
50,000
– –
ACGCW
136
ACP Holdings Acquisition Corp Warrants
ACGCW
$37.5K ﹤0.01%
+125,000
New +$38.5K
BLUWW
137
Blue Water Acquisition Corp III Warrant
BLUWW
$3.64M
$28.5K ﹤0.01%
75,000
– –
WLIIW
138
Willow Lane Acquisition Corp II Warrants
WLIIW
$27.8K ﹤0.01%
+31,250
New +$24.5K
LEGO.WS
139
Legato Merger Corp IV Warrants
LEGO.WS
$27.7K ﹤0.01%
66,667
– –
LAFAR
140
LaFayette Acquisition Corp Rights
LAFAR
$25K ﹤0.01%
250,000
– –
FGIIW
141
FG Imperii Acquisition Corp Warrants
FGIIW
$2.1M
$25K ﹤0.01%
100,000
– –
CHECW
142
Chenghe Acquisition III Co Warrants
CHECW
$20.5K ﹤0.01%
100,000
– –
EVAC.WS
143
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$19.9K ﹤0.01%
50,000
– –
LWACW
144
LightWave Acquisition Corp Warrants
LWACW
$1.73M
$15.5K ﹤0.01%
50,000
– –
BRLSW icon
145
Borealis Foods Inc Warrant
BRLSW
$971K
$9.4K ﹤0.01%
200,000
– –
OYSER
146
Oyster Enterprises II Acquisition Corp Rights
OYSER
$8.26K ﹤0.01%
75,000
– –
ECXWW
147
ECARX Holdings Warrants
ECXWW
$691K
$5K ﹤0.01%
125,000
– –
MSAIW icon
148
MultiSensor AI Holdings Warrant
MSAIW
$986K
$4.35K ﹤0.01%
150,000
– –
APLMW icon
149
Apollomics Inc Warrant
APLMW
$1.24M
$2.61K ﹤0.01%
130,000
– –
ORIQW
150
Origin Investment Corp I Warrant
ORIQW
$18.8K
$1.66K ﹤0.01%
15,000
– –
4 5
6
7 8

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, 683 Capital Management held 257 positions worth $2.04B, up 6.3% from $1.92B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

683 Capital Management withdrew a net $149M in Q2 2026, closing 104 positions and reducing 47 holdings. Its most notable exit was Eli Lilly, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 683 Capital Management opened a new position in Unity worth $17.6M.

  • 683 Capital Management's largest Q2 2026 buy was Unity: 615,000 shares worth $17.6M.
  • 683 Capital Management added most to Gossamer Bio in Q2 2026, an estimated $9.54M increase.
  • 683 Capital Management's biggest Q2 2026 reduction was Astrana Health, cutting an estimated $17.6M.
  • 683 Capital Management fully exited Eli Lilly in Q2 2026, selling an estimated $15.3M.
  • 683 Capital Management's ten largest holdings make up 47% of its $2.04B portfolio in Q2 2026.
  • 683 Capital Management opened 21 new positions and closed 104 in Q2 2026.
  • 683 Capital Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.